Creasman WT - Search Results

1

Replacement therapy for breast cancer survivors. A pilot study.

DiSaia PJ, Grosen EA, Odicino F, Cowan B, Pecorelli S, Wile AG, Creasman WT. DiSaia PJ, et al. Among authors: creasman wt. Cancer. 1995 Nov 15;76(10 Suppl):2075-8. doi: 10.1002/1097-0142(19951115)76:10+<2075::aid-cncr2820761328>3.0.co;2-2. Cancer. 1995. PMID: 8635003

2

An experience with estrogen replacement therapy in breast cancer survivors.

Brewster WR, DiSaia PJ, Grosen EA, McGonigle KF, Kuykendall JL, Creasman WT. Brewster WR, et al. Among authors: creasman wt. Int J Fertil Womens Med. 1999 Jun-Aug;44(4):186-92. Int J Fertil Womens Med. 1999. PMID: 10499739 Clinical Trial.

3

WHI: Now that the dust has settled: a commentary.

Creasman WT, Hoel D, Disaia PJ. Creasman WT, et al. Am J Obstet Gynecol. 2003 Sep;189(3):621-6. doi: 10.1067/s0002-9378(03)00978-5. Am J Obstet Gynecol. 2003. PMID: 14526278 Review. No abstract available.

4

Hormone replacement and breast cancer risk: reconsidering the data.

Creasman WT, DiSaia PJ. Creasman WT, et al. Oncology (Williston Park). 2009 Nov 15;23(12):1099-100; author reply 1100, 1102. Oncology (Williston Park). 2009. PMID: 20017294 Free article. No abstract available.

5

Screening in ovarian cancer.

Creasman WT, DiSaia PJ. Creasman WT, et al. Am J Obstet Gynecol. 1991 Jul;165(1):7-10. doi: 10.1016/0002-9378(91)90213-b. Am J Obstet Gynecol. 1991. PMID: 1853918

6

Conservative surgical management of superficially invasive stage I vulvar carcinoma.

Berman ML, Soper JT, Creasman WT, Olt GT, DiSaia PJ. Berman ML, et al. Among authors: creasman wt. Gynecol Oncol. 1989 Dec;35(3):352-7. doi: 10.1016/0090-8258(89)90078-4. Gynecol Oncol. 1989. PMID: 2599471

7

Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis. A Gynecologic Oncology Group study.

Creasman WT, Zaino RJ, Major FJ, DiSaia PJ, Hatch KD, Homesley HD. Creasman WT, et al. Am J Obstet Gynecol. 1998 Jan;178(1 Pt 1):62-5. doi: 10.1016/s0002-9378(98)70628-3. Am J Obstet Gynecol. 1998. PMID: 9465805

8

A randomized trial of cyclophosphamide, doxorubicin, and cisplatin with or without bacillus Calmette-Guerin in patients with suboptimal stage III and IV ovarian cancer: a Gynecologic Oncology Group study.

Creasman WT, Omura GA, Brady MF, Yordan E, DiSaia PJ, Beecham J. Creasman WT, et al. Gynecol Oncol. 1990 Dec;39(3):239-43. doi: 10.1016/0090-8258(90)90244-f. Gynecol Oncol. 1990. PMID: 2258063 Clinical Trial.

9

Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: a Gynecologic Oncology Group Study.

Williams L, Brunetto VL, Yordan E, DiSaia PJ, Creasman WT. Williams L, et al. Among authors: creasman wt. Gynecol Oncol. 1997 Aug;66(2):171-8. doi: 10.1006/gyno.1997.4806. Gynecol Oncol. 1997. PMID: 9264559 Clinical Trial.

10

Significance of true surgical pathologic staging: a Gynecologic Oncology Group Study.

Creasman WT, DeGeest K, DiSaia PJ, Zaino RJ. Creasman WT, et al. Am J Obstet Gynecol. 1999 Jul;181(1):31-4. doi: 10.1016/s0002-9378(99)70431-x. Am J Obstet Gynecol. 1999. PMID: 10411790

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

273 results

Search Page

Filters